Antengene (HKSE:06996) YoY Rev. per Sh. Growth : -17.19% (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Antengene YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Antengene's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 was -17.19%.

Antengene's Revenue per Share for the six months ended in Jun. 2024 was HK$0.11.

Antengene YoY Rev. per Sh. Growth Historical Data

The historical data trend for Antengene's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antengene YoY Rev. per Sh. Growth Chart

Antengene Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

416.07

-58.48

31.67

Antengene Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial								242.86	25.49	-104.17	-17.19	775.00

Antengene YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Antengene's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(0.12	-	0.289)	/	\| 0.289 \|
=	-58.48 %

Antengene's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Jun. 2024 )
=	(Revenue per Share (Q: Jun. 2024 )	-	Revenue per Share (Q: Jun. 2023 ))	/	\| Revenue per Share (Q: Jun. 2023 )) \|
=	(0.106	-	0.128)	/	\| 0.128 \|
=	-17.19 %

Antengene YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Antengene's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Antengene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Antengene Corp Ltd (HKSE:06996) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN

Website

https://www.antengene.com

Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically it operates in Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.

Executives

Xyxy Holdings Ltd.	2201 Interest of corporation controlled by you
Boyu Group, Llc	2201 Interest of corporation controlled by you
Boyu Capital Group Holdings Ltd	2201 Interest of corporation controlled by you
Tong Xiaomeng	2201 Interest of corporation controlled by you
Jay Mei 2025 Grat	2201 Interest of corporation controlled by you
Mei Jay	2201 Interest of corporation controlled by you
Jay Mei 2023 Grat	2201 Interest of corporation controlled by you
Fountainvest China Capital Partners Gp3 Ltd.	2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd.
The Core Trust Company Limited	2301 Trustee
Tct (bvi) Limited	2501 Other
Fountainvest China Capital Partners Fund Iii, L.p.	2201 Interest of corporation controlled by you
Begonia Investment Ltd.	2101 Beneficial owner
Fmr Llc	2201 Interest of corporation controlled by you
Fidelity Investment Trust	2101 Beneficial owner

Antengene Headlines

No Headlines